From Analysis:
How does P2RY12-mediated VSMC dysfunction contribute to cerebrovascular neurodegeneration?
While the study establishes P2RY12's role in VSMC foam cell formation in atherosclerosis, the connection to brain vascular pathology and neurodegeneration remains unexplored. This gap is critical given P2RY12's known roles in microglia and vascular cognitive impairment. Gap type: open_question Source paper: The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis. (2021, Autophagy, PMID:32160082)
These hypotheses emerged from the same multi-agent debate that produced this hypothesis.
Foam cell–transformed cerebral VSMCs release excessive extracellular ATP/ADP via pannexin-1 channels, hyperactivating microglial P2RY12 and driving pro-inflammatory (M1) microglial polarization. Activated microglia secrete IL-1β, TNF-α, and MMP-9, further destabilizing cerebral VSMCs and the BBB, creating a self-reinforcing neuroinflammatory loop. This hypothesis is weakened by the oversimplified assumption that microglial P2RY12 is pro-inflammatory; in AD/tau contexts, P2RY12 is often a homeostatic/surveillance marker and is commonly downregulated in disease-associated microglia near plaques. The spatial biology is also problematic: diffusible purines are rapidly degraded by ectonucleotidases, making long-range VSMC-to-microglia purinergic signaling uncertain.
No AI visual card yet
Mechanism:
In cerebral arterial VSMCs, sustained P2RY12 activation inhibits autophagy flux (via mTOR pathway engagement), leading to accumulation of damaged organelles and protein aggregates within the vascular wall. This compromises the structural integrity of the neurovascular unit, resulting in blood-brain barrier (BBB) leakage, pericyte detachment, and downstream
Below I’m using the source paper’s core result as the anchor: P2RY12 activation in VSMCs promoted foam-cell formation by suppressing autophagy through PI3K-AKT-MTOR in an atherosclerosis model, not specifically in cerebral VSMCs or neurodegeneration [PMID:32160082](https://pubmed.ncbi.nlm.nih.gov/32160082/). That extrapolation is the main vulnerability across most hypotheses.
Overall Skeptical Read
The strongest part of the hypothesis set is the P2RY12 → VSMC autophagy/foam-cell axis. The weakest part is the leap from peripheral/aortic atherosclerotic VSMCs to brain vascular pathology, BB
Bottom Line
The most feasible surviving program is not “repurpose ticagrelor for Alzheimer’s.” It is a staged target-validation program testing whether P2RY12 is functionally present in cerebral VSMCs and whether its inhibition restores VSMC autophagy enough to alter CAA, BBB leakage, or perfusion.
Best surviving hypotheses:
No price history recorded yet
No clinical trials data available
No knowledge graph edges recorded
neurodegeneration | 2026-04-07 | archived
No comments yet. Be the first to comment!